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Since publication of our article [1], we have noticed an
error in labelling the p-value of one of the results. The
original document read:
“The direction of association of BL1 with pCR or
minimal residual cancer burden (RCB) in the 2188-gene
model was similar (OR = 1.91) but did not reach signifi-
cance (OR = 0.14).”
This has been corrected to:
“The direction of association of BL1 with pCR or
minimal residual cancer burden (RCB) in the 2188-gene
model was similar (OR = 1.91) but did not reach signifi-
cance (p = 0.14).”
We regret the error.
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